Related Experiment Video
Updated: Aug 6, 2025

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
Published on: March 15, 2016
Molecular docking analysis of VEGF with compounds from tomato
Madhan Krishnan1, Shyamaladevi Babu1, Suni Ann Thomas2
1Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, chengalpattu District, Tamilnadu, India.
Compounds found in tomatoes show potential for Non-small cell lung carcinoma (NSCLC) drug discovery. Molecular docking analysis revealed that Kaempferol-3-O, Quercetin, Naringenin, and Rutin effectively bind to vascular endothelial growth factor (VEGF).
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Vascular Endothelial Growth Factor (VEGF) plays a critical role in angiogenesis and is implicated in Non-small Cell Lung Carcinoma (NSCLC) progression.
- Targeting VEGF is a recognized strategy in NSCLC treatment, necessitating the search for novel therapeutic agents.
Purpose of the Study:
- To investigate the potential of naturally occurring compounds from tomatoes as inhibitors of VEGF.
- To perform molecular docking analyses to assess the binding affinity of tomato-derived compounds with VEGF for drug discovery applications.
Main Methods:
- Utilized molecular docking simulations to analyze the interactions between VEGF and selected phytochemicals from tomatoes.
- Evaluated binding energies and interaction patterns to identify compounds with high affinity for VEGF.
Main Results:
- Kaempferol-3-O, Quercetin, Naringenin, and Rutin demonstrated significant binding affinity to VEGF.
- These compounds exhibited optimal binding, suggesting their potential as VEGF inhibitors.
Conclusions:
- Tomato-derived compounds, specifically Kaempferol-3-O, Quercetin, Naringenin, and Rutin, show promise for NSCLC drug discovery.
- Further research into these compounds could lead to the development of new therapeutic strategies targeting VEGF in lung cancer.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...

